ABVC

American BriVision (Holding) Corporation (ABVC) | Rumor.io

American BriVision (Holding)

ABVC

Attention (50-day avg)0%

Attention rank (50-day avg)#3,481

Bullish sentiment (50-day avg)100%

Price to earnings ratio0.01

Market capitalization28M

Earnings per share-0.29

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-8.4M

Social

What share of all stock conversation is about ABVC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% 0	0% +0	0% 0

Jul 8

$ABVC is expected to reach $10 by the end of the month.
The shorts are maxed out, and investors are advised to cover their positions to avoid further losses.
$ABVC is seen as a potential "beast" with some investors questioning whether it's too late to join the momentum.

Generated by AI

Sentiment

Of the messages about ABVC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +17.49
Bearish	—	—	—	0% -17.49

Bullish· Apr 25

The stock has shown resilience in holding its bottom price of $1.38, and a break above $1.65 could lead to higher prices.
The company has a history of significant price movements, including a 1:10 reverse in July last year and a 89mil volume-driven price surge to over $2 in October.
The stock is experiencing high demand, with a limited float of only 1,000 shares available, and a high cost to borrow fee of 125.02%, indicating that shorts are feeling the heat.

Bearish· Apr 24

$ABVC is experiencing a significant momentum loss, potentially indicating that its upward trend has reversed.
Short sellers are betting against ABVC, with a large volume of short sales suggesting a high likelihood of a price drop.
ABVC's price is vulnerable to a significant decline, with some analysts predicting a potential price drop to $3 by 8pm if negative news emerges.

Generated by AI

Topics

Of the messages about ABVC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	100%	95.35%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%
Macro	—	0%	0%	0%
Technical Analysis	—	0%	0%	4.65%

Announcements· Jan 3

ABVC BioPharma, Inc. entered into a definitive global licensing agreement with AiBtl on November 12, 2023, for the Company's CNS drugs with the indications of MDD and ADHD.
The agreement requires AiBtl to deliver 46 million shares to ABVC as the first milestone payment, valued at $460 million, and may receive up to $7 million in cash and 5% royalties of net sales, up to $200 million, upon further milestones.
ABVC received 46 million shares from AiBtl as the first milestone payment, with the shares valued at $10 per share, and the Company expects AiBtl to achieve further milestones under the agreement.

Technical Analysis· Oct 27

ABVC BioPharma, Inc. is in a 1.33-1.43 consolidation flag, with a potential break expected.
A breakout above 1.50 is considered important, with a target of 2.00 if resistance is cleared.
The stock needs to bounce hard at the open and clear 1.80s for it to have a chance, with a potential retest of the high of day (HOD) if it breaks through resistance.

Generated by AI

Community

Of the messages about ABVC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	12.5%	33.94%
Newcomers	100%	100%	87.5%	66.06%

Regulars· Oct 26

The author notes that $ABVC's behavior is often similar to past trades, making it a good example of a momentum strategy that can make one uncomfortable but ultimately successful.
The author shares a "hall of fame trade" where they traded full size on $ABVC, but notes they were ready to triple if it moved higher towards $4, and are now worried about regretting their cover.
The author sees a possible double bottom setup on $ABVC, and notes that the stock has positive news, suggesting it's worth keeping an eye on, with a potential target of $3.30+ for profit.

Newcomers· Oct 26

Many newcomers are taking advantage of the stock's recent price movement, with some achieving significant gains and others experiencing losses.
Some users are sharing their strategies for buying and selling the stock, including taking advantage of gaps and dips, and using stop-loss orders.
The licensing agreement between ABVC BioPharma and a third party has been a major catalyst for the stock's recent price movement, with some users speculating about the potential implications of this agreement.

Generated by AI

Also Discussed

Investors talking about ABVC also mention

#	Name	Attention
1	Better Therapeutics, Inc.BTTX	0%new
2	PaxMedica Inc.PXMD	0%0
3	Apollomics Inc.APLM	0%0
4	Bone Biologics CorpBBLG	0%+0
5	Vivos Therapeutics, Inc.VVOS	0%+0
6	ParaZero Technologies Ltd.PRZO	0%+0
7	Naya Biosciences Inc.INVO	0%0
8	AAGR - African Agriculture Holdings Inc.	——
9	SAI - SAI.TECH Global Corporation	——
10	Evaxion A/S American Depositary ShareEVAX	0%0

American BriVision (Holding) Corporation

Healthcare
Biotechnology

ABVC Biopharma Inc. is a clinical-stage biopharmaceutical company focused on developing new drugs and medical devices derived from plants. The company works across therapeutic areas including central nervous system disorders, oncology, hematology, and ophthalmology, using botanical science and licensed research to advance candidates through early and mid-stage clinical development. Its current portfolio includes multiple drug programs and medical devices designed to address unmet medical needs, with an emphasis on proof-of-concept studies and collaborative development. ABVC Biopharma also operates an asset-light model that relies on licensing, partnerships, and clinical trial execution to move products toward commercialization. Headquartered in Fremont, California, ABVC Biopharma serves as a specialized participant in the broader biotechnology market, combining plant-based innovation with drug and device development.

Website

Location

44370 Old Warm Springs Boulevard

Fremont, CA, 94538

United States

Social

What share of all stock conversation is about ABVC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% 0	0% +0	0% 0

Jul 8

$ABVC is expected to reach $10 by the end of the month.
The shorts are maxed out, and investors are advised to cover their positions to avoid further losses.
$ABVC is seen as a potential "beast" with some investors questioning whether it's too late to join the momentum.

Generated by AI

Sentiment

Of the messages about ABVC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +17.49
Bearish	—	—	—	0% -17.49

Bullish· Apr 25

The stock has shown resilience in holding its bottom price of $1.38, and a break above $1.65 could lead to higher prices.
The company has a history of significant price movements, including a 1:10 reverse in July last year and a 89mil volume-driven price surge to over $2 in October.
The stock is experiencing high demand, with a limited float of only 1,000 shares available, and a high cost to borrow fee of 125.02%, indicating that shorts are feeling the heat.

Bearish· Apr 24

$ABVC is experiencing a significant momentum loss, potentially indicating that its upward trend has reversed.
Short sellers are betting against ABVC, with a large volume of short sales suggesting a high likelihood of a price drop.
ABVC's price is vulnerable to a significant decline, with some analysts predicting a potential price drop to $3 by 8pm if negative news emerges.

Generated by AI

Topics

Of the messages about ABVC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	100%	95.35%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%
Macro	—	0%	0%	0%
Technical Analysis	—	0%	0%	4.65%

Announcements· Jan 3

ABVC BioPharma, Inc. entered into a definitive global licensing agreement with AiBtl on November 12, 2023, for the Company's CNS drugs with the indications of MDD and ADHD.
The agreement requires AiBtl to deliver 46 million shares to ABVC as the first milestone payment, valued at $460 million, and may receive up to $7 million in cash and 5% royalties of net sales, up to $200 million, upon further milestones.
ABVC received 46 million shares from AiBtl as the first milestone payment, with the shares valued at $10 per share, and the Company expects AiBtl to achieve further milestones under the agreement.

Technical Analysis· Oct 27

ABVC BioPharma, Inc. is in a 1.33-1.43 consolidation flag, with a potential break expected.
A breakout above 1.50 is considered important, with a target of 2.00 if resistance is cleared.
The stock needs to bounce hard at the open and clear 1.80s for it to have a chance, with a potential retest of the high of day (HOD) if it breaks through resistance.

Generated by AI

Community

Of the messages about ABVC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	12.5%	33.94%
Newcomers	100%	100%	87.5%	66.06%

Regulars· Oct 26

The author notes that $ABVC's behavior is often similar to past trades, making it a good example of a momentum strategy that can make one uncomfortable but ultimately successful.
The author shares a "hall of fame trade" where they traded full size on $ABVC, but notes they were ready to triple if it moved higher towards $4, and are now worried about regretting their cover.
The author sees a possible double bottom setup on $ABVC, and notes that the stock has positive news, suggesting it's worth keeping an eye on, with a potential target of $3.30+ for profit.

Newcomers· Oct 26

Many newcomers are taking advantage of the stock's recent price movement, with some achieving significant gains and others experiencing losses.
Some users are sharing their strategies for buying and selling the stock, including taking advantage of gaps and dips, and using stop-loss orders.
The licensing agreement between ABVC BioPharma and a third party has been a major catalyst for the stock's recent price movement, with some users speculating about the potential implications of this agreement.

Generated by AI

American BriVision (Holding)

Social

Jul 8

Sentiment

Bullish· Apr 25

Bearish· Apr 24

Topics

Announcements· Jan 3

Technical Analysis· Oct 27

Community

Regulars· Oct 26

Newcomers· Oct 26

Also Discussed

American BriVision (Holding) Corporation

Company Information

Location

Also Discussed

Social

Jul 8

Sentiment

Bullish· Apr 25

Bearish· Apr 24

Topics

Announcements· Jan 3

Technical Analysis· Oct 27

Community

Regulars· Oct 26

Newcomers· Oct 26